Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Fred Hutchinson Cancer Research Center

Fred Hutchinson Cancer Research Center

Sep 11, 2020

Genomic Epidemiology Studies Retrace Sources of Early SARS-CoV-2 Outbreaks in US, Europe

By combining genome sequence data with phylogenetics and other clues, two teams looked at the SARS-CoV-2 introductions that sparked outbreaks in North America and Europe.

Sep 01, 2020

PNAS Papers on SARS-CoV-2 Diversity, Viral Detection Assay, New Guinea Singing Dog Ancestry

In PNAS this week: genetic diversity of SARS-CoV-2 indicates neutral evolution, portable RT-LAMP method to detect SARS-CoV-2, and more.

Apr 13, 2020

SARS-CoV-2 Genomes Let Researchers Retrace Viral Spread, Mitigation Effects

Researchers have been using Nextstrain, which includes data for thousands of SARS-CoV-2 genomes, to study how the virus accrues mutations over time.

Apr 07, 2020

Multiomic Approach Measures Protein Expression, RNA Transcript Levels of Single Cells

The researchers applied their approach to study the heterogeneity of immune cells and adapted a visualization tool to analyze the data.

Mar 25, 2020

Still Following It

Bloomberg writes that Fred Hutchinson Cancer Research Center's Trevor Bedford and his colleagues continue to use viral genomics to track SARS-CoV-2.

Feb 20, 2020

Lucid Diagnostics, Fred Hutchinson Cancer Research Center Ink Esophageal Cancer Biomarker Deal

The PAVmed subsidiary will have the option to license the biomarkers for a year after the completion of a Phase II study evaluating their accuracy.

Nov 27, 2019

Genome Biology Papers Look at Latino Gut Microbiomes, Gynecological Tumor Drug Responses, More

In Genome Biology this week: analysis of gut microbiomes from the Hispanic Community Health Study/Study of Latinos, collection of patient-derived tumor cells from gynecological cancers, and more.

Oct 10, 2019

Mission Bio Lands $2M NCI SBIR Grant to Advance Minimal Residual Disease Detection

The single-cell genomics firm will collaborate with Fred Hutchinson Cancer Research Center on a targeted sequencing panel for MRD monitoring in AML.

Oct 02, 2019

SEngine Precision Medicine Raises $5.1M in Series A Financing

The Seattle-based firm will use the funding to improve AI integration and further develop its Paris 3D tumor organoid diagnostic and drug discovery platform.

Sep 11, 2019

Genome Research Describes Platform for Ranking Pathogenic Variants, Analysis of Commensal E. Coli, More

In Genome Research this week: PeCanPIE platform for finding, annotating, and ranking pathogenic variants; commensal Escherichia coli analysis; and more.

Pages

The Scan

This Time, Novavax

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Shortened Visas for Some Students

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

New York's Own Review

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

Science Papers Examine Y Chromosomes of Archaic Humans, Schistosomiasis Therapeutic Targets

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.